Specially trained doctors will be able to provide a prescription for the possession and use of medical cannabis for patients with certain types of conditions instead of having to apply for a license. This was decided Tuesday by the Knesset Health Committee, and the change in regulations will enter into force 180 days after their publication.
Until now, to get medical cannabis legally, a patient had to obtain a license with the approval of the ministry or certain doctors who were trained for this.
The new regulations state that from now on, some applicants – those who suffer from epilepsy, Crohn’s disease, dementia, autism (without an age limit), malignant cancers, multiple sclerosis, AIDS, and terminally ill patients whose life expectancy does not exceed six months – will no longer need a license.
They will be able to get a prescription from doctors who will undergo special training on the subject (not including family doctors, pediatricians, or internal medicine specialists).
To read the complete article, go to www.jpost.com
Announcements
Vacancies
Israel: Accessibility to medical cannabis to be made easier for some
Publication date:
Receive the daily newsletter in your email for free | Click here
Other news in this sector:
- 2023-09-28 Hold lifted on cannabis products with detected Aspergillus mold
- 2023-09-28 NZ legislation leads cannabis company to export strains overseas
- 2023-09-28 US: Cannabis banking act approved by Senate Committee for the first time
- 2023-09-27 US (ME): Medical cannabis industry worries proposed rules create ‘new obstacles’ for their businesses
- 2023-09-27 US (PA): Senate passes bill allowing more growers to sell directly to patients
- 2023-09-27 US (AK): State relaxes rules for cannabis ads, allows free samples
- 2023-09-27 US (MN): As registration deadline approaches, count of hemp businesses reaches 1,250
- 2023-09-27 US (NY): Regulator plans 1,500 new cannabis licenses to sell surplus
- 2023-09-26 US (MT): Former testing laboratory says Montana is ignoring cannabis testing rules
- 2023-09-26 US (MO): Confusion continues over how hemp was processed in recalled Missouri cannabis products
- 2023-09-25 US (CO): Boulder County’s cannabis industry goes green
- 2023-09-25 US (NJ): Regulators to introduce edibles guidelines as state market takes hold
- 2023-09-25 US (MN): State's cannabis head resigns after reports she sold illegal cannabis products
- 2023-09-22 "Have a voice in the DEA application process"
- 2023-09-22 US: House Democrats file cannabis legalization and expungements bill
- 2023-09-21 US (RI): Judge rules cannabis grower can’t sell products as regulators seek to revoke license
- 2023-09-21 US: Bipartisan senators officially file revised cannabis banking bill ahead of key committee vote
- 2023-09-21 Thai lawmakers plan fresh push to tighten use of cannabis
- 2023-09-20 US (NJ): Regulators propose permits that would let dispensaries partner with research institutions
- 2023-09-20 US (ME): Office of Cannabis Policy discusses contaminants found in medical cannabis
